Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing

Abousheishaa AA 1 , Lazim NHM 2 , Tang SL 3 , Sulaiman AH 3 , Huri HZ 4 , Guan NC 3

Affiliations 

  • 1 Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: dr.ayasheishae@gmail.com
  • 2 Faculty of Languages and Linguistics, University of Malaya, Kuala Lumpur, Malaysia
  • 3 Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia
Patient Educ Couns, 2022 Jul;105(7):2466-2474.
PMID: 34844812 DOI: 10.1016/j.pec.2021.11.007

Abstract

OBJECTIVES: This study aimed to develop and assess the effectiveness of an encounter decision aid for Malaysian patients with MDD to support treatment decision-making during the consultation.

METHODS: The decision aid prototype was developed following a literature review and six focus groups. Alpha testing assessed its comprehensibility, acceptability, usability and desirability through user-centered cognitive interviews. Beta-testing evaluated preliminary evidence on its efficacy using the SDM Scale and PDMS. Feasibility was assessed by timing the consultation.

RESULTS: The alpha testing demonstrated that the decision aid was patient-oriented, comprehensible, comprehensive, concise and objective with an appealing design. Beta-testing indicated that PtDA significantly increased patients satisfaction with SDM from patients' [83.32 (13.92) vs 85.76 (13.80); p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications